Leases
The Company leases office space located in West Chester, Pennsylvania that serves as the Company's headquarters. The initial term expires on September 1, 2027. Base rent over the initial term is approximately $2.4 million, and the Company is also responsible for its share of the landlord's operating expenses.
The Company leased office space in Scotch Plains, New Jersey under an agreement classified as an operating lease, which commenced on May 1, 2022 and was due to expire on April 30, 2025. In September 2024, the Company terminated the agreement effective November 30, 2024. No termination fees were incurred.
The Company entered into a fleet program to provide vehicles for its sales force. The vehicles are leased for a term of 52 months and classified as finance leases. During the year ended December 31, 2025, the Company recognized a right-of-use asset of $0.3 million and a lease liability of $0.3 million related to these finance leases. During the year ended December 31, 2024, a total of 57 vehicle leases were terminated and the lessor sold those vehicles at auction. The Company recognized an impairment of the right-of-use asset based on estimated fair value of the vehicles of $0.3 million and a loss on termination of leases of $19,000 for the year ended December 31, 2024. The Company reduced lease liability by $1.5 million and right-of-use assets by $1.6 million related to the terminated leases for the year ended December 31, 2024.
The components of lease expense are as follows (in thousands):
For the Year Ended December 31,
20252024
 Finance lease cost:
Amortization right-of-use assets$352 $619 
Interest on lease liabilities77 179 
Operating lease:
Operating lease costs$341 $387 
Maturities of the Company's operating leases, excluding short-term leases, as of December 31, 2025 are as follows (in thousands):
OperatingFinance
2026$366 $468 
2027246 413 
2028— 211 
2029— 61 
Thereafter— 
Total lease payments612 1,155 
Less imputed interest(29)(107)
Lease liability$583 $1,048 
The weighted average remaining lease term and discount rates for the Company's leases as of December 31, 2025 are as follows:
OperatingFinance
Weighted average remaining lease term (years)1.672.74
Weighted average discount rate6.25%7.73%
Free Sentinel

Want the next Verrica Pharmaceuticals Inc. leases disclosure the moment it drops?

Set a Sentinel and we'll alert you the moment Verrica Pharmaceuticals Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.

Track for free

Historical Timeline

Fiscal YearFiled
2025Mar 11, 2026Showing above
2023Feb 29, 2024
2022Mar 6, 2023
2021Mar 2, 2022
2020Mar 17, 2021
2019Mar 13, 2020

About Leases Disclosures

Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.

Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.